• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚组识别方法在差异化治疗效果中的比较研究:性能指标与建议。

A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations.

机构信息

1 Statistics - Global Product Development, Pfizer Inc., New York, NY, USA.

2 Department of Biostatistics, School of Public Health & Health Professions, SUNY Buffalo, NY, USA.

出版信息

Stat Methods Med Res. 2018 Dec;27(12):3658-3678. doi: 10.1177/0962280217710570. Epub 2017 Jun 20.

DOI:10.1177/0962280217710570
PMID:28629264
Abstract

Subgroup identification with differential treatment effects serves as an important step towards precision medicine, as it provides evidence regarding how individuals with specific characteristics respond to a given treatment. This knowledge not only supports the tailoring of treatment strategies but also prompts the development of new treatments. This manuscript provides a brief overview of the issues associated with the methodologies aimed at identifying subgroups with differential treatment effects, and studies in depth the operational characteristics of five data-driven methods that have appeared recently in the literature. The performance of the methods under study to identify correctly the covariates affecting treatment effects is evaluated via simulation and under various conditions. Two clinical trial data sets are also used to illustrate the application of these methods. Discussion and recommendations pertaining to the use of these methods are provided, with emphasis on the relative performance of the methods under the conditions studied.

摘要

亚组识别与差异化治疗效果是精准医学的重要步骤,因为它为具有特定特征的个体对特定治疗的反应方式提供了证据。这些知识不仅支持治疗策略的定制,也促使新的治疗方法的开发。本文简要概述了与旨在识别差异化治疗效果亚组的方法相关的问题,并深入研究了最近在文献中出现的五种数据驱动方法的操作特点。通过模拟和在各种条件下,评估了所研究方法识别影响治疗效果的协变量的性能。还使用了两个临床试验数据集来说明这些方法的应用。讨论并建议了使用这些方法的相关问题,重点关注在研究条件下方法的相对性能。

相似文献

1
A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations.亚组识别方法在差异化治疗效果中的比较研究:性能指标与建议。
Stat Methods Med Res. 2018 Dec;27(12):3658-3678. doi: 10.1177/0962280217710570. Epub 2017 Jun 20.
2
Model-Based Recursive Partitioning for Subgroup Analyses.用于亚组分析的基于模型的递归划分
Int J Biostat. 2016 May 1;12(1):45-63. doi: 10.1515/ijb-2015-0032.
3
Regularized outcome weighted subgroup identification for differential treatment effects.用于差异治疗效果的正则化结果加权亚组识别
Biometrics. 2015 Sep;71(3):645-53. doi: 10.1111/biom.12322. Epub 2015 May 11.
4
Studying treatment-effect heterogeneity in precision medicine through induced subgroups.通过诱导亚组研究精准医学中的治疗效果异质性。
J Biopharm Stat. 2019;29(3):491-507. doi: 10.1080/10543406.2019.1579220. Epub 2019 Feb 22.
5
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.随机对照试验中的亚组分析:量化假阳性和假阴性风险
Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330.
6
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.临床药物开发中亚组识别方法的比较:模拟研究与监管考量
Pharm Stat. 2019 Oct;18(5):600-626. doi: 10.1002/pst.1951. Epub 2019 Jul 3.
7
Subgroup identification for treatment selection in biomarker adaptive design.生物标志物适应性设计中用于治疗选择的亚组识别
BMC Med Res Methodol. 2015 Dec 9;15:105. doi: 10.1186/s12874-015-0098-7.
8
Bayesian credible subgroup identification for treatment effectiveness in time-to-event data.贝叶斯可信亚组识别在生存时间数据中的治疗效果。
PLoS One. 2020 Feb 26;15(2):e0229336. doi: 10.1371/journal.pone.0229336. eCollection 2020.
9
Finding the best subgroup with differential treatment effect with multiple outcomes.寻找具有多个结局的差异化治疗效果的最佳亚组。
Stat Med. 2024 Jun 15;43(13):2487-2500. doi: 10.1002/sim.10083. Epub 2024 Apr 15.
10
A general statistical framework for subgroup identification and comparative treatment scoring.用于亚组识别和比较治疗评分的通用统计框架。
Biometrics. 2017 Dec;73(4):1199-1209. doi: 10.1111/biom.12676. Epub 2017 Feb 17.

引用本文的文献

1
Heterogeneous treatment effect estimation for observational data using model-based forests.基于模型森林的观察性数据异质处理效应估计。
Stat Methods Med Res. 2024 Mar;33(3):392-413. doi: 10.1177/09622802231224628. Epub 2024 Feb 8.
2
Inference on subgroups identified based on a heterogeneous treatment effect in a post hoc analysis of a clinical trial.基于临床试验事后分析中异质治疗效果识别的亚组推断。
Clin Trials. 2023 Aug;20(4):370-379. doi: 10.1177/17407745231173055. Epub 2023 May 11.
3
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials.
临床试验中生物识别监测技术数据的分析与解读考量
Digit Biomark. 2022 Aug 29;6(3):83-97. doi: 10.1159/000525897. eCollection 2022 Sep-Dec.
4
A two-stage adaptive clinical trial design with data-driven subgroup identification at interim analysis.两阶段自适应临床试验设计,在中期分析时采用数据驱动的亚组识别。
Pharm Stat. 2022 Sep;21(5):1090-1108. doi: 10.1002/pst.2208. Epub 2022 Mar 24.
5
Exploring differential response to an emergency department-based care transition intervention.探讨基于急诊科的护理转介干预的差异化反应。
Am J Emerg Med. 2021 Dec;50:640-645. doi: 10.1016/j.ajem.2021.09.026. Epub 2021 Sep 16.
6
Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps.用于精准健康经济学与结果研究(P-HEOR)的机器学习:应用概念综述与下一步举措
J Health Econ Outcomes Res. 2020 May 12;7(1):35-42. doi: 10.36469/jheor.2020.12698. eCollection 2020.
7
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.临床药物开发中亚组识别方法的比较:模拟研究与监管考量
Pharm Stat. 2019 Oct;18(5):600-626. doi: 10.1002/pst.1951. Epub 2019 Jul 3.